Advanced search
Publication Cover
Acta Orthopaedica Volume 87, 2016 - Issue 5
Journal homepage
1,241
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Arthroplasty for tenosynovial giant cell tumors

17 patients followed for 0.2 to 15 years

Floortje G M VerspoorDepartment of Orthopedics, Radboud University Medical Center, Nijmegen, the NetherlandsCorrespondence[email protected]
,
Gerjon HanninkDepartment of Orthopedics, Radboud University Medical Center, Nijmegen, the Netherlands
,
Anouk ScholteDepartment of Orthopedics, Radboud University Medical Center, Nijmegen, the Netherlands
,
Ingrid C M Van Der GeestDepartment of Orthopedics, Radboud University Medical Center, Nijmegen, the Netherlands
&
H W Bart SchreuderDepartment of Orthopedics, Radboud University Medical Center, Nijmegen, the Netherlands
Pages 497-503 | Received 06 Feb 2016, Accepted 03 May 2016, Published online: 30 Jun 2016

  • Bunting D, Kampa R, Pattison R. An unusual case of pigmented villonodular synovitis after total knee arthroplasty. J Arthroplasty 2007; 22 (8): 1229–31.
  • Chiari C, Pirich C, Brannath W, Kotz R, Trieb K. What affects the recurrence and clinical outcome of pigmented villonodular synovitis? Clin Orthop Relat Res 2006; 450: 172–8.
  • de Kam D C, Busch V J, Veth R P, Schreurs B W. Total hip arthroplasties in young patients under 50 years: limited evidence for current trends. A descriptive literature review. Hip Int 2011; 21 (5): 518–25.
  • de saint Aubain Somerhausen N, van de Rijn M. Tenosynovial giant cell tumour, diffuse/localized type. In: Fletcher C D, Bridge J A, Hogedoorn P C, Mertens F, eds. WHO classification of tumours of Soft Tissue and Bone 2013; 5 (4th ed. Lyon: IARC Press).
  • Della Valle A G, Piccaluga F, Potter H G, Salvati E A, Pusso R. Pigmented villonodular synovitis of the hip: 2- to 23-year followup study. Clin Orthop Relat Res 2001; (388): 187–99.
  • Dines J S, DeBerardino T M, Wells J L, Dodson C C, Shindle M, DiCarlo E F, et al. Long-term follow-up of surgically treated localized pigmented villonodular synovitis of the knee. Arthroscopy 2007; 23 (9): 930–7.
  • Flandry F, McCann S B, Hughston J C, Kurtz D M. Roentgenographic findings in pigmented villonodular synovitis of the knee. Clin Orthop Relat Res 1989; (247): 208–19.
  • Fortina M, Carta S, Gambera D, Crainz E, Ferrata P, Maniscalco P. Recovery of physical function and patient’s satisfaction after total hip replacement (THR) surgery supported by a tailored guide-book. Acta Biomed 2005; 76 (3): 152–6.
  • Friedman T, Chen T, Chang A. MRI diagnosis of recurrent pigmented villonodular synovitis following total joint arthroplasty. HSS J 2013; 9 (1): 100–5.
  • Garellick G, Malchau H, Herberts P. Specific or general health outcome measures in the evaluation of total hip replacement. A comparison between the Harris hip score and the Nottingham Health Profile. J Bone Joint Surg Br 1998; 80 (4): 600–6.
  • Gitelis S, Heligman D, Morton T. The treatment of pigmented villonodular synovitis of the hip. A case report and literature review. Clin Orthop Relat Res 1989; (239): 154–60.
  • Hamlin B R, Duffy G P, Trousdale R T, Morrey B F. Total knee arthroplasty in patients who have pigmented villonodular synovitis. J Bone Joint Surg 1998; 80 (1): 76–82.
  • Healy W L, Della Valle C J, Iorio R, Berend K R, Cushner F D, Dalury D F, et al. Complications of total knee arthroplasty: standardized list and definitions of the Knee Society. Clin Orthop Relat Res 2013; 471 (1): 215–20.
  • Insall J N. Presidential address to The Knee Society. Choices and compromises in total knee arthroplasty. Clin Orthop Relat Res 1988; (226): 43–8.
  • Jones C A, Voaklander D C, Suarez-Alma M E. Determinants of function after total knee arthroplasty. Phys Ther 2003; 83 (8): 696–706.
  • Lawrence T, Moskal J T, Diduch D R. Analysis of routine histological evaluation of tissues removed during primary hip and knee arthroplasty. J Bone Joint Surg 1999; 81 (7): 926–31.
  • Ma X, Xia C, Wang L, Zhao L, Liu H, He J. An Unusual Case of Pigmented Villonodular Synovitis 14 Years After Total Hip Arthroplasty. J Arthroplasty 2011; 26 (2): 339.e5–e6.
  • Ma X, Shi G, Xia C, Liu H, He J, Jin W. Pigmented villonodular synovitis: a retrospective study of seventy five cases (eighty one joints). Int Orthop 2013; 37 (6): 1165–70.
  • Murphey M D, Rhee J H, Lewis R B, Fanburg-Smith J C, Flemming D J, Walker E A. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics 2008; 28 (5): 1493–518.
  • Roorda L D, Jones C A, Waltz M, Lankhorst G J, Bouter L M, van der Eijken J W, et al. Satisfactory cross cultural equivalence of the Dutch WOMAC in patients with hip osteoarthritis waiting for arthroplasty. Ann Rheum Dis 2004; 63 (1): 36–42.
  • van der Heijden L, Mastboom M J, Dijkstra P D, van de Sande M A. Functional outcome and quality of life after the surgical treatment for diffuse-type giant-cell tumour around the knee: a retrospective analysis of 30 patients. Bone Joint J 2014; 96-B (8): 1111–8.
  • VanderZee K I, Sanderman R, Heyink J W, de Haes H. Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status. Int J Behav Med 1996; 3 (2): 104–22.
  • Vercoulen J H M, Alberts M, Bleijenberg G. The Checklist Individual Strength (CIS). Gedragstherapie 1999; 32: 131–6.
  • Verspoor F G, van der Geest I C, Vegt E, Veth R P, van der Graaf W T, Schreuder H W. Pigmented villonodular synovitis: current concepts about diagnosis and management. Future Oncol 2013; 9 (10): 1515–31.
  • Verspoor F G, Zee A A, Hannink G, van der Geest I C, Veth R P, Schreuder H W. Long-term follow-up results of primary and recurrent pigmented villonodular synovitis. Rheumatology (Oxford) 2014; 53 (11): 2063–70.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.